Home > Financial Ratios > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
EV/Core EBITDA

    Back to All Ratios
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for MEDICAMEN BIOTECH
Please provide your vote to see the results

MEDICAMEN BIOTECH Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 31.0919.4831.1331.3232.67

What is the latest EV/Core EBITDA ratio of MEDICAMEN BIOTECH ?

The latest EV/Core EBITDA ratio of MEDICAMEN BIOTECH is 31.09 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202531.09
Mar202419.48
Mar202331.13
Mar202231.32
Mar202132.67

How is EV/Core EBITDA of MEDICAMEN BIOTECH Trending?

Years EV/Core EBITDA % Change
Mar2025 31.09
59.60
Mar2024 19.48
-37.42
Mar2023 31.13
-0.61
Mar2022 31.32
-4.13
Mar2021 32.67 -

Other Financial Ratios of MEDICAMEN BIOTECH


Compare EV/Core EBITDA ratio of peers of MEDICAMEN BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH ₹337.3 Cr -7.6% 2.9% -45% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹419,332.0 Cr 4.7% -0.3% -3.1% Stock Analytics
DIVIS LABORATORIES ₹170,800.0 Cr 2.3% 6.8% 9.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹141,578.0 Cr 2.5% -1.7% 26.5% Stock Analytics
DR REDDYS LABORATORIES ₹113,075.0 Cr 11.3% 7.6% 12.5% Stock Analytics
CIPLA ₹105,662.0 Cr 5.9% 7.3% -14.1% Stock Analytics


MEDICAMEN BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH

-7.6%

2.9%

-45%

SENSEX

-3%

5.8%

-3.4%


You may also like the below Video Courses